PCM
CRDF icon

Princeton Capital Management’s Cardiff Oncology CRDF Stock Holding History

Princeton Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-141
Closed – – 120
2019
Q3 		$0 Hold
141
– – ﹤0.01% 246
2019
Q2 		$0 Sell
141
-99
-41% -$317 ﹤0.01% 247
2019
Q1 		$1K Buy
240
+2
+0.8% +$7 ﹤0.01% 234
2018
Q4 		$1K Hold
238
– – ﹤0.01% 251
2018
Q3 		$1K Hold
238
– – ﹤0.01% 256
2018
Q2 		$1K Buy
238
+1
+0.4% +$17 ﹤0.01% 286
2018
Q1 		$6K Hold
237
– – ﹤0.01% 259
2017
Q4 		$5K Buy
+237
New +$10.5K ﹤0.01% 100

Other funds holding CRDF

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LWA
LWS Wealth Advisors Basking Ridge, New Jersey $266M AUM 12.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return